Immunomodulatory Yersinia outer proteins (Yops)–useful tools for bacteria and humans alike

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Virulence

• Publication date

  2017-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/21505594.2017.1303588PMID 28296562PMCID PMC5711447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets.

  2017cited by this paper
• Recent in vivo advances in cell-penetrating peptide-assisted drug delivery

  2016cited by this paper
• High‐Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH

  2016cited by this paper
• A Comparative Analysis of the Mechanism of Toll-Like Receptor-Disruption by TIR-Containing Protein C from Uropathogenic Escherichia coli

  2016cited by this paper
• SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression.

  2016cited by this paper
• Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family

  2016cited by this paper
• The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases

  2016cited by this paper
• Chicoric acid binds to two sites and decreases the activity of the YopH bacterial virulence factor

  2016cited by this paper
• Yersinia YopJ negatively regulates IRF3-mediated antibacterial response through disruption of STING-mediated cytosolic DNA signaling.

  2016cited by this paper
• Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease

  2016cited by this paper
• Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain

  2016cited by this paper
• The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Yersinia pseudotuberculosis Is Required for Early Targeting of YopH and In vivo Virulence

  2016cited by this paper
• Yersinia type III effectors perturb host innate immune responses.

  2016cited by this paper
• Type III Secretion: Building and Operating a Remarkable Nanomachine.

  2016cited by this paper
• The Yersinia Type III secretion effector YopM Is an E3 ubiquitin ligase that induced necrotic cell death by targeting NLRP3

  2016cited by this paper
• Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agent.

  2016cited by this paper
• The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.

  2016cited by this paper
• Bacterial Effector Nanoparticles as Breast Cancer Therapeutics.

  2016cited by this paper
• Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells

  2016cited by this paper
• Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose medicine new paradigm

  2015cited by this paper
• Current activities of the Yersinia effector protein YopM.

  2015cited by this paper
• The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?

  2015cited by this paper
• Role of Rho kinase signal pathway in inflammatory bowel disease.

  2015cited by this paper
• Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector‐mediated subversion of host innate immune pathways

  2015cited by this paper
• DEGylation Enhanced the Stability of Peptide-siRNA Complexes in Serum.

  2015cited by this paper
• Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague

  2015cited by this paper
• Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization

  2015cited by this paper
• Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier

  2015cited by this paper
• Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs.

  2015cited by this paper
• Emerging Roles of Focal Adhesion Kinase in Cancer

  2015cited by this paper
• Observations of membrane fusion in a liposome dispersion: the missing fusion intermediate?

  2015cited by this paper
• Observations of membrane fusion in a liposome dispersion: the missing fusion intermediate?

  2015cited by this paper
• Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells

  2015cited by this paper
• A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4.

  2015cited by this paper
• Gαq controls rheumatoid arthritis via regulation of Th17 differentiation

  2015cited by this paper
• Protein Phosphatases of Pathogenic Bacteria: Role in Physiology and Virulence.

  2015cited by this paper
• V‐antigen homologs in pathogenic gram‐negative bacteria

  2014cited by this paper
• Targeting IL-10 in Auto-immune Diseases

  2014cited by this paper
• A new class of salicylic acid derivatives for inhibiting YopH of Yersinia pestis.

  2014cited by this paper
• Caspase-3 Mediates the Pathogenic Effect of Yersinia pestis YopM in Liver of C57BL/6 Mice and Contributes to YopM's Function in Spleen

  2014cited by this paper
• Role of Th17 Cells in the Pathogenesis of Human IBD

  2014cited by this paper
• Manipulation of pro-inflammatory cytokine production by the bacterial cell-penetrating effector protein YopM is independent of its interaction with host cell kinases RSK1 and PRK2

  2014cited by this paper
• The GAP Activity of Type III Effector YopE Triggers Killing of Yersinia in Macrophages

  2014cited by this paper
• Targeting Rho-GTPases in immune cell migration and inflammation

  2014cited by this paper
• Bidentate Inhibitors of Protein Tyrosine Phosphatases

  2014cited by this paper
• The Secreted Peptide PIP1 Amplifies Immunity through Receptor-Like Kinase 7

  2014cited by this paper
• Natural products with protein tyrosine phosphatase inhibitory activity.

  2014cited by this paper
• 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.

  2014influential reference
• Direct Neutralization of Type III Effector Translocation by the Variable Region of a Monoclonal Antibody to Yersinia pestis LcrV

  2014cited by this paper
• Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases

  2014cited by this paper
• Integrin-Mediated First Signal for Inflammasome Activation in Intestinal Epithelial Cells

  2014cited by this paper
• IQGAP1 Is Important for Activation of Caspase-1 in Macrophages and Is Targeted by Yersinia pestis Type III Effector YopM

  2014cited by this paper
• Neutrophil elastase inhibitor suppresses IL-17 based inflammation of murine experimental colitis.

  2014cited by this paper
• Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling

  2014cited by this paper
• Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death

  2014cited by this paper
• Analysis of T3SS-independent autonomous internalization of the bacterial effector protein SspH1 from Salmonella typhimurium

  2014cited by this paper
• YopK controls both rate and fidelity of Yop translocation

  2013cited by this paper
• p130Cas: a key signalling node in health and disease.

  2013cited by this paper
• Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors

  2013cited by this paper
• Cytotoxic Necrotizing Factor-Y Boosts Yersinia Effector Translocation by Activating Rac Protein*

  2013cited by this paper
• Yersinia pseudotuberculosis Efficiently Escapes Polymorphonuclear Neutrophils during Early Infection

  2013cited by this paper
• Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP.

  2013cited by this paper
• Identification of secreted bacterial proteins by noncanonical amino acid tagging

  2013cited by this paper
• Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis.

  2013cited by this paper
• Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.

  2013influential reference
• Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

  2013cited by this paper
• Cell type-specific function of TAK1 in innate immune signaling.

  2013cited by this paper
• The N terminus of SKAP55 enables T cell adhesion to TCR and integrin ligands via distinct mechanisms

  2013cited by this paper
• Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection.

  2013cited by this paper
• Yersinia enterocolitica inactivates NK cells.

  2013cited by this paper
• The Escherichia coli Phosphotyrosine Proteome Relates to Core Pathways and Virulence

  2013cited by this paper
• Integrin Signaling in Cancer Cell Survival and Chemoresistance

  2012cited by this paper
• Neutrophil function: from mechanisms to disease.

  2012cited by this paper
• Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.

  2012cited by this paper
• Bacterial Virulence Proteins as Tools to Rewire Kinase Pathways in Yeast and Immune Cells

  2012cited by this paper
• YopJ-Induced Caspase-1 Activation in Yersinia-Infected Macrophages: Independent of Apoptosis, Linked to Necrosis, Dispensable for Innate Host Defense

  2012cited by this paper
• TRIM32 Protein Modulates Type I Interferon Induction and Cellular Antiviral Response by Targeting MITA/STING Protein for K63-linked Ubiquitination*

  2012cited by this paper
• The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing.

  2012cited by this paper
• Bone remodelling in inflammatory arthritis

  2012cited by this paper
• Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling

  2012cited by this paper
• Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery

  2012cited by this paper
• Expanding TRAF function: TRAF3 as a tri-faced immune regulator

  2011cited by this paper
• Insight into Bacterial Virulence Mechanisms against Host Immune Response via the Yersinia pestis-Human Protein-Protein Interaction Network

  2011cited by this paper
• The RACK1 Signaling Scaffold Protein Selectively Interacts with Yersinia pseudotuberculosis Virulence Function

  2011cited by this paper
• A Yersinia Effector with Enhanced Inhibitory Activity on the NF-κB Pathway Activates the NLRP3/ASC/Caspase-1 Inflammasome in Macrophages

  2011cited by this paper
• Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease

  2011cited by this paper
• Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.

  2011cited by this paper
• Anti-cytokine therapies for psoriasis.

  2011cited by this paper
• Translocation of surface-localized effectors in type III secretion

  2011cited by this paper
• Functional domains and motifs of bacterial type III effector proteins and their roles in infection.

  2011cited by this paper
• Delineation of Regions of the Yersinia YopM Protein Required for Interaction with the RSK1 and PRK2 Host Kinases and Their Requirement for Interleukin-10 Production and Virulence

  2010cited by this paper
• The Acetyltransferase Activity of the Bacterial Toxin YopJ of Yersinia Is Activated by Eukaryotic Host Cell Inositol Hexakisphosphate

  2010cited by this paper
• Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System

  2010cited by this paper
• The C-Terminal Tail of Yersinia pseudotuberculosis YopM Is Critical for Interacting with RSK1 and for Virulence

  2010cited by this paper
• A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines

  2010influential reference
• The regulation of IL-10 production by immune cells

  2010cited by this paper
• ROS‐inhibitory activity of YopE is required for full virulence of Yersinia in mice

  2010influential reference
• YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia

  2010cited by this paper
• Destabilization of YopE by the Ubiquitin-Proteasome Pathway Fine-Tunes Yop Delivery into Host Cells and Facilitates Systemic Spread of Yersinia enterocolitica in Host Lymphoid Tissue

  2010cited by this paper
• Yersinia Virulence Factor YopM Induces Sustained RSK Activation by Interfering with Dephosphorylation

  2010cited by this paper

• A bacterial YopJ-family acetyltransferase suppresses host immune response by Nε-acetylation of JAK1.

  2026cites this paper
• Yersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils

  2025cites this paper
• Molecular Mimicry by Bacterial Effector Proteins

  2025cites this paper
• Genomic Characterization of Vibrio spp. in Asian Seabass (Lates calcarifer, Bloch, 1790) Following Field Vaccination Using a Feed-Based Inactivated Vaccine against Vibriosis

  2025cites this paper
• A Narrative Review on the Multifaceted Roles of Galectins in Host–Pathogen Interactions During Helicobacter pylori Infection

  2025cites this paper
• Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition

  2024cites this paper
• Yersinia pestis actively inhibits the production of extracellular vesicles by human neutrophils

  2024cites this paper
• Distinct mechanisms of type 3 secretion system recognition control LTB4 synthesis in neutrophils and macrophages

  2024cites this paper
• Yersinia pestis and pneumonic plague: Insight into how a lethal pathogen interfaces with innate immune populations in the lung to cause severe disease.

  2024cites this paper
• Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB4 Synthesis in Neutrophils versus Macrophages

  2024cites this paper
• Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague

  2024cites this paper
• Comparative sequence analysis elucidates the evolutionary patterns of Yersinia pestis in New Mexico over thirty-two years

  2023cites this paper
• GENETIC RELATEDNESS OF PATHOGENIC YERSINIA

  2023cites this paper
• Macrophage innate immune responses delineate between defective translocon assemblies produced by Yersinia pseudotuberculosis YopD mutants

  2023cites this paper
• Yersinia enterocolitica in Crohn’s disease

  2023cites this paper
• Characterizing prophages in the genus Fusobacterium.

  2023cites this paper
• Immune evasion and persistence in enteric bacterial pathogens

  2023cites this paper
• Type III secretion by Yersinia pseudotuberculosis is reliant upon an authentic N‐terminal YscX secretor domain

  2022cites this paper
• Yersinia pestis antibiotic resistance: a systematic review

  2022cites this paper
• LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis

  2021cites this paper
• Nuclear trafficking of bacterial effector proteins

  2021cites this paper
• Evolution of virulence in a novel family of transmissible mega-plasmids.

  2021cites this paper
• Plague vaccines: new developments in an ongoing search

  2021cites this paper
• Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production

  2021cites this paper
• A general view on virulence determinants and infection strategies of Yersinia enterocolitica

  2020cites this paper
• Pan-genomics, drug candidate mining and ADMET profiling of natural product inhibitors screened against Yersinia pseudotuberculosis.

  2020cites this paper
• Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague

  2020cites this paper
• Utilization of Galectins by Pathogens for Infection

  2020cites this paper
• Staying out or Going in? The Interplay between Type 3 and Type 5 Secretion Systems in Adhesion and Invasion of Enterobacterial Pathogens

  2020influential citation
• The cell-penetrating YopM protein-functionalized quantum dot-plasmid DNA conjugate as a novel gene delivery vector.

  2020cites this paper
• Editorial: The Pathogenic Yersiniae–Advances in the Understanding of Physiology and Virulence, Second Edition

  2019cites this paper
• Delivering Signal-Altering Bacterial Effector Proteins to Mammalian Cells Using Cell-Penetrating Peptide Technology

  2019cites this paper
• Toxicity and Immune Response

  2019cites this paper
• Measurement of Yersinia Translocon Pore Formation in Erythrocytes.

  2019cites this paper
• Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague

  2019cites this paper
• The species‐spanning family of LPX‐motif harbouring effector proteins

  2018cites this paper
• Bacterial riboswitches and RNA thermometers: Nature and contributions to pathogenesis

  2018cites this paper
• All in-Multiple parallel strategies for intracellular delivery by bacterial pathogens.

  2018cites this paper
• A plague of actin disassembly

  2017cites this paper
• Usurping bacterial virulence factors as self-delivery vehicles for therapeutic use

  2017cites this paper
• The TAL Effector AvrBs3 from Xanthomonas campestris pv. vesicatoria Contains Multiple Export Signals and Can Enter Plant Cells in the Absence of the Type III Secretion Translocon

  2017cites this paper